Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

By J. Crouse, J. Raichlen, W. Riley, G. Evans, M. Palmer, D. O'leary, Diederick E. Grobbee, M. Bots. Journal of the American Medical Association (JAMA), 2007

744 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/397c1f3a05f1d0341515f1226c94566d3073da38

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Stein
2. C. Korcarz
3. R. Todd Hurst
4. E. Lonn
5. Christopher B. Kendall
6. E. Mohler
7. C. Rembold
8. Wendy S. Post

Citations in the corpus

• Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. (2008, methodology): “The Measuring Effects on Intima-Media Thickness: An Evaluation of Rosuvastatin (METEOR) Study demonstrated that middle-aged adults at apparently low to intermediate CVD risk but with increased CIMT (N 984) benefited from statin therapy that they otherwise would not have qualified for based on curren”
• SibNet: Sibling Convolutional Encoder for Video Captioning (2018, neutral): “We utilize Bleu [28], METEOR [7], ROUGE [19] 𝐜 𝑒 𝐯 𝑒 Semantic loss 𝐿 s = 𝐿 𝑠 ({𝐯 𝑒 ,𝐜 𝑒 }) and CIDEr [43] as our evaluation metrics, which are commonly used for performance evaluation of video captioning methods.”